Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

Authors

Institutions

Publication Details

Journal
The Lancet
Published
2025-02-01
DOI
https://doi.org/10.1016/s0140-6736(24)02808-3
Citations
94
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
130.59

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

Silvia Rota, Simon S. Skene, Alexa King, Vincenzo Libri et al.
94 citations
The Lancet
Parkinson's Disease Mechanisms and Treatments
130.59
article

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

Silvia Rota, Simon S. Skene, Alexa King, Vincenzo Libri, Jacqueline Kerr, Nirosen Vijiaratnam, Monty Silverdale, Jessica Welch, Thomas Foltynie, К. Ray Chaudhuri, Patricia Limousin, Edwin Jabbari, Dilan Athauda, Jemma Inches, Camille Carroll, Rachel Gibson, Nigel H. Greig, Grace Auld, Christine Girges, John Dickson, Kashfia Chowdhury, Kevin Power, Gordon W. Duncan, Helen Matthews, Sabina Melander, Bethan Blackledge, Lucia Batzu, Huw R. Morris, Steve Hibbert, Rachel McComish, Yazhou Li, Sonia Gandhi, Alan Wong, Abigail Patrick, Jessica Whiston, Sarah Gallen
article en
94 citations

Abstract

No abstract available for this paper.
The LancetVol. 405(10479)
Queen Mary University of London (GB), Royal Free London NHS Foundation Trust (GB), Manchester Academic Health Science Centre (GB), Western General Hospital (GB), The Francis Crick Institute (GB), University of Surrey (GB), National Institute for Health and Care Research (GB), Manchester University NHS Foundation Trust (GB), Parkinson's UK (GB), King's College Hospital NHS Foundation Trust (GB), National Institute on Aging (US), Oxford University Hospitals NHS Trust (GB), University College London (GB), University of Plymouth (GB)
Cure Parkinson's Trust, Medical Research Council, Efficacy and Mechanism Evaluation Programme
Good health and well-being
Openalex Percentile: Top 0%
Parkinson's Disease Mechanisms and Treatments
130.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.